XGN
Exagen Inc
NASDAQ: XGN · HEALTHCARE · DIAGNOSTICS & RESEARCH
$2.90
+5.07% today
Updated 2026-04-30
Market cap
$65.91M
P/E ratio
—
P/S ratio
0.99x
EPS (TTM)
$-0.93
Dividend yield
—
52W range
$3 – $12
Volume
0.3M
Exagen Inc (XGN) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-7.48M | $-6.87M | $-10.77M | $-11.90M | $-10.97M | $-9.30M | $-9.71M | $-14.08M | $-20.27M | $-32.14M | $-14.46M | $-13.28M | $-13.63M |
| Capital expenditures | $440000.00 | $172000.00 | $649000.00 | $805000.00 | $567000.00 | $199000.00 | $403000.00 | $455000.00 | $2.37M | $4.32M | $828000.00 | $515000.00 | $641000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $116000.00 | $152000.00 | $279000.00 | $287000.00 | $187000.00 | $114000.00 | $572000.00 | $2.69M | $4.73M | $4.70M | $3.62M | $1.76M | $2.16M |
| Free cash flow | $-7.92M | $-7.04M | $-11.42M | $-12.71M | $-11.54M | $-9.50M | $-10.11M | $-14.54M | $-22.64M | $-36.46M | $-15.29M | $-13.79M | $-14.27M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $6.74M | $142000.00 | $390000.00 | — | $9.94M | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | $0.00 | $0.00 | $0.00 | $0.00 | — | — | $41.99M | — | — | — | — |